Case report: Toripalimab plus anlotinib in postoperative recurrent renal pelvic sarcomatoid urothelial carcinoma

BackgroundSarcomatoid urothelial carcinoma (SUC) is a rare renal malignancy. Its biological malignancy is high, the prognosis is poor, diagnostic and treatment options are few, and there is no standard treatment plan.Case presentationIn this case, a 64-year-old woman was hospitalized with fever and...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Xinrong Hu, Lin Deng, Yufei Pan, Guozhen Zhang, Xiaolan Ruan, Xinlan Jiang, Hao Shen, Lei Zhao, Jun Dong
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2024-09-01
Edice:	Frontiers in Oncology
Témata:	toripalimab anlotinib postoperative recurrence renal pelvic urothelial carcinoma upper-tract urothelial carcinoma sarcomatoid urothelial carcinoma
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1397855/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!